Omnicell (OMCL) shares recently dipped about 2% over the past day, sparking renewed curiosity about its valuation, especially after a volatile stretch for healthcare technology stocks. Investors may ...
Hosted on MSN
Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results , with sales up 18.6% year on year to $306.9 million. On the other hand, next quarter’s revenue guidance of $260 million was ...
Ratings for Omnicell (NASDAQ:OMCL) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their ...
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the second quarter 2025, before market open on Thursday, ...
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the third quarter 2025, before market open on Thursday, ...
Five robotics-driven stocks - PATH, EMR, TRMB, OMCL and LECO - are set to gain traction heading into late 2025.
A month has gone by since the last earnings report for Omnicell (OMCL). Shares have lost about 0.4% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced OmniSphere, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback